Full Text View
Tabular View
No Study Results Posted
Related Studies
Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
This study has been completed.
Study NCT00001728   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polyostotic Fibrous Dysplasia
Additional conditions recognized in this trial
Fibrous Dysplasia of Bone
Fibrous Dysplasia, Polyostotic
Syndrome
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Disease
Musculoskeletal Diseases
Osteochondrodysplasias
Pathologic Processes
Interventions listed in this trial
Fosamax (Alendronate)
Additional drug interventions recognized in this trial
Alendronate
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Dental and Craniofacial Research (NIDCR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services